This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The lab, which works with AstraZeneca, Merck, Pfizer, Israel Biotech Fund and Teva Pharmaceuticals, as well as tech company Amazon Web Services, is currently accepting new applicants for its new challenge.
Together, the organizations will seek to harness the power of generative AI to help pharmaceutical and lifescience manufacturers drive efficiencies and business value while improving patient outcomes.
We’re excited to be back for another episode of the LifeSciences Today Podcast by Healthcare IT Today. Hes worked at the intersection of science, pharma, and innovation for years and now hes helping world-class scientist-entrepreneurs turn bold ideas into sustainable businesses that serve patients around the globe.
EVERSANA ORCHESTRATE MLR is a game-changer for the lifescience industry, said Jim Lang, CEO. By harnessing the power of Amazon Bedrock, EVERSANA will empower lifesciences companies with the AI tools they need to mitigate a significant pain point for the healthcare industry administrative burden.
This capability is attracting pharmaceutical and lifescience companies, health care providers and research organizations to take a closer look at Seqster’s offering. Takeda is one of the organizations that has implemented Seqster’s solution, leveraging real-time data for research and patient services.
Basel, Switzerland 28, January 2025 Lyfegen , a global innovator in drug market access, pricing, and rebate management, has announced a transformative collaboration with EVERSANA , a leading provider of global commercial services to the lifesciences industry, to revolutionize drug pricing and access through artificial intelligence-driven insights.
The funding will support Briya’s mission to transform how data is exchanged between healthcare organizations and lifesciences organizations, with particular emphasis on supporting the United States health ecosystem. The company’s scalable data exchange platform enables hospitals to capitalize on their patient data. .”
About EVERSANA EVERSANA is a leading independent provider of global services to the lifesciences industry. The companys integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers.
Check out our community’s Pharma predictions: Dave Latshaw, CEO at BioPhy The competitive dynamics of the pharmaceutical industry will undergo substantial reorganization in 2025. The role of AI-native pharmaceutical companies will expand significantly in 2025, building on the momentum of billions in investment from previous years.
BOSTON–( BUSINESS WIRE )– Labviva , the AI-driven lifesciences digital marketplace that simplifies and scales purchasing processes, announced today that it has secured $20 million in Series A financing led by Biospring Partners, with participation from existing investors Senator Investment Group, B Capital Group, and Glasswing Ventures.
Our mission is to accelerate the commercialization of breakthrough innovations like the AUTAC platform for health impact, and we welcome Automera and ALSP to Singapore’s growing lifesciences translational community.” Together, we advance Singapore as a global lifesciences translational hub.
Abbott, one of the first lifescience companies to exhibit at CES back in 2022, announced the HeartMates program here at #CES2024 today as part of a panel titled Ahead of the Game: Revolutionizing Athlete Safety with Emerging Health Tech. .”
The lifesciences industry continues to innovate, providing diagnostics, therapeutics, and treatments to support the population through the COVID-19 pandemic. Lifesciences companies are also high-impact job creators, with surveyed companies forecasting nearly 6,000 employees in 2023 — up 1,800 (44.3%) from 2022.
The company offers payers, providers, and pharmaceutical companies the ability to transform claims and EHR datasets into analytics-ready data tables via an open-source data model with built-in normalization, data quality testing, and enrichment.
In May this year, Civica Rx signed an agreement with Xellia Pharmaceuticals to supply essential antibiotics to Civica’s member health systems. Note that Cigna acquired Express Scripts, the pharmacy benefit management company, last year which was the health insurance company’s on-ramp to lifesciences.
“push”) model where HCPs can access all the support they need from lifescience, insurance and pharmacy companies industry-wide, on their terms, in one place. They consider prescribing support from pharmaceutical companies and other institutions, if delivered in the right way, as helpful as ever.
The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges. .
That a pharmaceutical company executive is speaking on the main stage at CES speaks to digital health’s mainstreaming beyond elite athletes and smartwatches that track activity.
CitiusTech , a leader in healthcare technology and consulting services, today announced that it has acquired Wilco Source , one of the world’s leading providers of Salesforce consulting and implementation services for healthcare and lifesciences companies. patient and provider portals) (Salesforce Communities).
The Report shows that the world’s leading pharmaceutical companies continue to spurn the opportunity to connect via social media at a local level. Roche Pharmaceuticals 3. Bayer (Pharmaceuticals Division) 4. Pfizer, Janssen, Novartis, Novo Nordisk, AbbVie and Takeda Pharmaceutical have at least 11 local apps available.
He sees three major developments: healthcare will become a digital-first system; decentralization will become a major theme for health and lifesciences organizations; and video will be part of every healthcare experience. You predict that decentralization will become a major theme for health and lifescience organizations.
Tom Lawry may be best-known as a leading voice on AI in health care; after all, hes written two very well-selling books on the topic, speaks all over the world on the subject, and in his most recent company-based gig helped lead Microsofts efforts in AI in health care and lifesciences.
The transaction was led by EQT LifeSciences investing from the LSP Health Economics Fund 2 and joined by prior investors Downing Ventures. As part of the transactions, Drew Burdon of EQT LifeSciences will join the Board of Directors. About EQT LifeSciences. About FundamentalVR. billion (USD 3.5
And note how Americans’ trust in hospitals — historically the top-trusted health care segment in the nation — eroded from 2018, tying with consumer health companies, and just north of biotech and lifescience organizations. Even trust with pharmaceutical companies increased that year.
Fujitsu, Toppan tie up for big data analysis Japanese companies Fujitsu and Toppan have entered into a business alliance to offer advanced big data analysis services for hospital organisations and pharmaceutical companies.
I collaborated with GoodRx on a “yellow paper” discussing The Health Consumers as Payer , with implications and calls-to-action for pharma and lifescience companies. You can download the paper at this link. The post The Patient as Prescription Drug Payer – The GoodRx Playbook appeared first on HealthPopuli.com.
IT vendor Salesforce is rolling out new healthcare tools designed to help healthcare and lifesciences organizations meet their patients, members and customers where they are to deliver the right care, at the right time, from anywhere.
BERLIN – October 7, 2024 – EVERSANA , a leading provider of global commercial services to the lifesciences industry, today announced the continued growth of its European footprint with a new office in Berlin, Germany, Europe’s largest pharmaceutical market.
With the proven success to save on average 48% production time from traditional agency models, TEDAVI meets the dynamic needs of the pharmaceutical and lifescience industries. CHICAGO – Aug. TEDAVI showcases next-generation innovation while reinforcing a commitment to “pharmatize AI.”
Kelly Nguyen is a multi-award-winning, seasoned executive with a proven track record in the pharmaceutical and healthcare industry. Dr. Kelly Nguyen is an experienced entrepreneur and executive with a proven track record in the pharmaceutical and healthcare industry. About Diversity Alliance for Science (DA4S).
Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients. Petra Jantzer, Ph.D.,
Built on a strong heritage in health innovation, Newel Health works in partnership with pharmaceutical companies, medical device manufacturers and other health and wellness stakeholders. Its team of experts, comprised of professionals in digital, data, behavioral, and scientific fields, have extensive experience in the lifesciences industry.
The following is a guest article by Steve Lazer, Global Healthcare & LifeSciences CTO at Dell Technologies. One rapidly advancing trend in healthcare and lifesciences is the shift from inefficient, expensive physical models to digital models tested in the virtual world.
A “one layered delivery network through which patients can move seamlessly as they age and their needs evolve” will be the new health care platform to meet patients’ demands by 2030, according to a forecast from KPMG’s Healthcare and LifeSciences Institute. delivery and financing system.
Chris McSpiritt, Head of LifeSciences at Domino Data Lab Next year will see AI-enhanced imaging technologies significantly improve diagnostic accuracy in radiology and pathology, empowering clinicians to make quicker and more reliable decisions at the point of care.
The newly appointed board members are: Jennifer Chavez, Senior Director, BioMed Realty Provides comprehensive commercial real estate transaction expertise and specialized business management services for BioMed Realtys Colorado portfolio, including the 23-building Flatiron Park, a hub for lifescience, quantum and technology innovation.
EVERSANA INTOUCH Healthware joins five full-service affiliates and four specialty affiliates serving clients across the globe with world-class strategy, next-generation branding and creative, and innovative solutions to propel the future of lifescience marketing. They are, however, fully owned and operated by EVERSANA.
The following is a guest article by Bill Young, Director of Healthcare & LifeSciences at SYSTRAN Keeping patient data confidential and secure remains a major healthcare challenge today, more than 25 years after the introduction of the 1996 Health Insurance Portability & Accountability Act or HIPAA.
The additional investment, led by Seroba LifeSciences and existing Deciphex investors, will allow Deciphex to continue developing its innovative products and services, to expand its presence in the UK, Canada, the Middle East and the US, and to strengthen its position as a leader in the field of digital pathology and AI.
Only a few pharmaceutical companies have integrated AI-based solutions in their processes. AI will keep its position as a major interest, both for investors and healthcare practitioners. Algorithms are still evolving, becoming faster and more accurate. In most cases, AI is used within pilot projects and has yet to be deployed.
Having worked within a variety of pharmaceutical organizations, Henry added that Cappellino is also a seasoned pro when it comes to approaching market access with a client-side perspective in mind. “We About Klick Health Klick Health is the world’s largest independent commercialization partner for lifesciences.
Pharmaceuticals garner the lowest score at 57, compared with biotech and lifesciences at 64. It’s important to note differences in trust across the five healthcare industry segments — and there are big differences.
However, while DTP technology could empower patients to advocate for the best possible treatment options, members of Congress and others are concerned about the potential conflict of interest for pharmaceutical companies offering direct sales. Lawmakers recently asked pharmaceutical companies questions about their tapping into virtual care.
The acquisition expands Linus Health’s operations into the lifesciences industry. Aural Analytics’ speech analytics software, called Speech Vitals, is used by leading healthcare systems and lifescience organizations in pharmaceutical research and clinical trials.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content